Catechin Gargling for Influenza Infection

Status Completed

Clinical Trial Summary

The purpose of this study is to clarify the preventive effects of catechin gargling on the influenza infection.

Clinical Trial Description

In-vitro experimental studies have revealed that tea catechin extracts induce preventive effects on influenza infection. However, few studies have been conducted on the effects of tea gargling on influenza infection, and the clinical evidence is unclear. Also there have been no studies reported on the gargling effects with tea catechin extracts on the prevention of influenza infection. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00239213
Study type	Interventional
Source	University of Shizuoka
Contact
Status	Completed
Phase	N/A
Start date	November 2005
Completion date	April 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00603811` - Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults	Phase 1
Completed	`NCT03784885` - A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult	Phase 2
Recruiting	`NCT05436444` - Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model	Phase 1
Completed	`NCT01201902` - A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine	Phase 3
Completed	`NCT00559975` - Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine	Phase 1
Terminated	`NCT00647465` - Effect of the Interferon Alpha Citizen by Sub-Lingual Way on the Humoral Immunizing Answer	Phase 3
Recruiting	`NCT01225770` - Gargling With Green Tea for Prophylaxis of Influenza Infection in Teenagers	Phase 3
Completed	`NCT01008020` - Effects of Tea Catechin Consumption on the Prophylaxis of Influenza Infection	N/A
Terminated	`NCT04933968` - Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant	Phase 1/Phase 2
Not yet recruiting	`NCT04298060` - DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)	Phase 2
Completed	`NCT01049490` - Dose Sparing Intradermal S-OIV H1N1 Influenza Vaccination Device	N/A
Completed	`NCT02367885` - Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants	Phase 1/Phase 2
Completed	`NCT02313155` - Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults	Phase 1/Phase 2
Completed	`NCT00812448` - Catechin Containing Mask for the Prevention of Influenza Infection	N/A
Active, not recruiting	`NCT05818124` - Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019)	Phase 1
Terminated	`NCT01160237` - Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM	Phase 3
Completed	`NCT03814720` - Dose, Safety, Tolerability and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine in Healthy Adults	Phase 1